.. Prescription-médicamenteuse, V. Conclusion, and .. , 53 C. Limites de l'étude, p.59

V. Ricci, P. Blotière, P. Weill, A. Simon, D. Tuppin et al., Diabète traité: quelles évolutions entre, pp.425-431, 2000.

S. Ardigo, L. Perrenoud, and P. J. , Diabète de la personne âgée : une prise en charge sur mesure

L. Monnier, G. Slama, B. Vialettes, and O. Ziegler, Nutrition and diabetes. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases, pp.207-216, 1995.

D. Bonds, J. Larson, A. Schwartz, E. Strotmeyer, J. Robbins et al., Risk of Fracture in Women with Type 2 Diabetes: the Women???s Health Initiative Observational Study, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.9, pp.3404-3410, 1991.
DOI : 10.1210/jc.2006-0614

J. F. Blicke, A. J. Barrou, Z. Brocker, P. De-rekeneire, N. Verny et al., Diabetes &Metabolism : Le diabète du sujet âgé, pp.84-93, 1999.

S. Inzucchi, R. Bergenstal, and J. Buse, Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), Diabetologia, pp.55-1577, 2012.

M. Hung, S. Chang, Y. Liu, J. Kuo, K. Chen et al., Disponible à partir de l'URL : agenceprd .ansm.sante.fr Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study, Lancet Diabetes Endocrinol, vol.2015, issue.128, pp.3605-614, 2014.

. Cnamts, Risque de cancer de la vessie chez les personnes diabétiques traitées par pioglitazone en France : une étude de cohorte sur les données du SNIIRAM et du PMSI. Caisse nationale de l'assurance maladie, 2011.

J. Orgiazzi, M. Raucoules-aime, H. Saltiel, D. Simon, G. Vanzetto et al., Traitement médicamenteux du diabéte de type 2 (Actualisation) Recommandation de bonne pratique, 2006.

A. Patel, S. Macmahon, and J. Chalmers, Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial, The Lancet, vol.370, issue.9590, pp.829-869, 2007.
DOI : 10.1016/S0140-6736(07)61303-8

W. Duckworth, C. Abraira, and T. Moritz, Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes, New England Journal of Medicine, vol.360, issue.2, pp.129-168, 2009.
DOI : 10.1056/NEJMoa0808431

. Haute-autorité-de-santé, Extrait de l'argumentaire scientifique de la RBP : « Stratégie médicamenteuse du contrôle glycémique du diabète de type 2 » Chapitre : Stratégie médicamenteuse ? patients ayant une insuffisance rénale chronique, 2013.

J. Carter, P. Stevens, J. Irving, and E. Lamb, Estimating glomerular filtration rate: comparison of the CKD-EPI and MDRD equations in a large UK cohort with particular emphasis on the effect of age, QJM, vol.104, issue.10, pp.104839-847, 2011.
DOI : 10.1093/qjmed/hcr077

C. Carbonnel, V. Seux, V. Pauly, C. Oddoze, C. Roubicek et al., Estimation of the glomerular filtration rate in elderly inpatients: Comparison of four methods, Rev Med Interne, issue.265, pp.29364-369, 2008.

L. Koppe, A. Klich, L. Dubourg, R. Ecochard, and A. Hadj-aissa, Performance of creatinine-based equations compared in older patients, Journal of Nephrology, vol.26, issue.4, pp.716-739, 2013.
DOI : 10.5301/jn.5000297

A. Douros, N. Ebert, J. O. Martus, P. Kreutz, R. Schaeffner et al., Estimating kidney function and use of oral antidiabetic drugs in elderly, Fundamental & Clinical Pharmacology, vol.81, issue.Suppl 2, pp.29-321, 2015.
DOI : 10.1111/fcp.12118

E. Schaeffner, N. Ebert, P. Delanaye, U. Frei, J. Gaedeke et al., Two Novel Equations to Estimate Kidney Function in Persons Aged 70 Years or Older, Annals of Internal Medicine, vol.157, issue.7, pp.157471-481, 2012.
DOI : 10.7326/0003-4819-157-7-201210020-00003

H. Pottel, L. Hoste, L. Dubourg, N. Ebert, E. Schaeffner et al., An estimated glomerular filtration rate equation for the full age spectrum, Nephrology Dialysis Transplantation, vol.31, issue.5, pp.31798-806, 2016.
DOI : 10.1093/ndt/gfv454

T. Kunt and F. Snoek, Barriers to insulin initiation and intensification and how to overcome them, International Journal of Clinical Practice, vol.9, issue.1 Suppl., pp.6-10, 2009.
DOI : 10.1111/j.1742-1241.2009.02176.x

S. Halimi and G. Reach, Comment a été conduite l'étude DAWN2 ? Données françaises, Comparaisons avec les autres pays. Médecine des maladies Métaboliques, p.516, 2013.

L. Bordier, M. Buysschaert, B. Bauduceau, J. Doucet, C. Verny et al., Predicting factors of hypoglycaemia in elderly type 2 diabetes patients: Contributions of the GERODIAB study, Diabetes & Metabolism, vol.41, issue.4, pp.41-301, 2015.
DOI : 10.1016/j.diabet.2015.03.001

J. Bremer, K. Jauch-chara, M. Hallschmid, S. Schmid, and B. Schultes, Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes, Diabetes Care, pp.321513-1517, 2009.

A. Abdelhafiz, L. Rodríguez-mañas, J. Morley, and A. Sinclair, Hypoglycemia in Older People - A Less Well Recognized Risk Factor for Frailty, Aging and Disease, vol.6, issue.2, pp.156-167, 2015.
DOI : 10.14336/AD.2014.0330

C. Eudo and T. Constans, Diabetes in the elderly: from healthy to disabled patients. La Revue de gériatrie, pp.9-609, 2011.

E. Huang, J. Liu, H. Moffet, P. John, and A. Karter, Glycemic Control, Complications, and Death in Older Diabetic Patients, Diabetes Care, pp.34-1329, 2011.

A. Schweizer, S. Dejager, and E. Bosi, Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial, Diabetes, Obesity and Metabolism, vol.48, issue.Suppl. 1, pp.11804-812, 2009.
DOI : 10.1111/j.1463-1326.2009.01051.x

A. Penfornis, I. Bourdel-marchasson, and S. Quere, Dejager SReal-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: The HYPOCRAS study 2012 BESANCON, Diabetes Metab, issue.416, pp.38-550, 2012.

C. Koro, B. Lee, and S. Bowlin, Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States, Clinical Therapeutics, vol.31, issue.11, pp.312608-2617, 2009.
DOI : 10.1016/j.clinthera.2009.10.020

A. Penfornis, J. Blicklé, B. Fiquet, S. Quéré, and S. Dejager, How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study, Vasc Health Risk Manag, pp.10341-352, 2014.

S. Bouée, A. Gaudin, E. Amelineau, and F. Bonnet, Traitements antidiab??tiques des patients diab??tiques de type 2 atteints d???une insuffisance r??nale mod??r??e ou s??v??re suivis en m??decine g??n??rale en France, Th??rapie, vol.68, issue.1, pp.19-26, 2013.
DOI : 10.2515/therapie/2013002